Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesMultidrug-Resistant Variants of HIV Type 1 Can Exist in Cells as Defective Quasispecies and Be Rescued by Superinfection with Other Defective HIV-1 Variants
The Journal of Infectious Diseases, 09/17/09
Quan Y et al. – The results are most likely attributable to recombination during second rounds of infection and suggest that defective HIV–1 variants may nonetheless constitute part of the HIV–1 reservoir.
Related Articles
HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants
Journal of Leukocyte Biology, 11/12/09
Relevance Score: 84%
HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays
Journal of Clinical Virology, 11/11/09
Relevance Score: 84%
The Heptad Repeat 2 Domain Is a Major Determinant for Enhanced Human Immunodeficiency Virus Type 1 (HIV-1) Fusion and Pathogenicity of a Highly Pathogenic HIV-1 Env
Journal of Virology, 11/11/09
Relevance Score: 84%
Glycoprotein 96-Mediated Presentation of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Human Leukocyte Antigen Class I-Restricted Peptide and Humoral Immune Responses to HIV-1 p24
Clinical and Vaccine Immunology, 11/03/09
Relevance Score: 84%
Retention and Attendance of Women Enrolled in a Large Prospective Study of HIV-1 in the United States
Journal of Women's Health, 10/01/09
Relevance Score: 84%
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor